Probiotics
Natural health product licensed in Canada
- Licence holder
- Amare Global
- NPN or DIN-HM
- 80090145
- Status
- Active licence
- Licence date
- 15 January 2019
- Revision date
- 13 January 2025
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Lactobacillus acidophilus Source : Cellule entière | 1.55 Milliards d'UFC | Not calculated |
| Lactobacillus acidophilus Source : LA-14 | 1.55 Milliards d'UFC | Not calculated |
| Bifidobacterium bifidum Source : BB-06 | 1 Milliards d'UFC | Not calculated |
| Bifidobacterium bifidum Source : Cellule entière | 1 Milliards d'UFC | Not calculated |
Non-medicinal ingredients
Hydroxypropyl méthylcellulose, Gomme arabique, Poudre d'Oryza Sativa (Riz), Huile de tournesol, Poudre d'enveloppes d'Oryza sativa (Riz), Gomme de gellane, Extrait de son d'Oryza sativa (Riz), Inuline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes, adolescents et enfants | Not specified | 2 Capsule | 1 day |
Uses authorised in Canada
Source of Probiotics. Helps support intestinal/gastrointestinal health. Could promote a favorable gut flora.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
If you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment), do not use this product.
- Précautions et mises en garde
If you have fever, vomiting, bloody diarrhoea or severe abdominal pain, consult a health care practitioner prior to use. If symptoms of digestive upset (e.g. diarrhea) occur, worsen, or persist beyond 3 days, discontinue use and consult a health care practitioner.
Source
Official Health Canada record, licence 80090145
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.